Woodmont Investment Counsel LLC Increases Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Woodmont Investment Counsel LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,928 shares of the healthcare conglomerate’s stock after purchasing an additional 1,404 shares during the period. UnitedHealth Group accounts for 0.9% of Woodmont Investment Counsel LLC’s holdings, making the stock its 29th biggest position. Woodmont Investment Counsel LLC’s holdings in UnitedHealth Group were worth $10,353,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Richelieu Gestion SA acquired a new stake in UnitedHealth Group during the fourth quarter worth about $26,000. CGC Financial Services LLC grew its holdings in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares in the last quarter. True Wealth Design LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $31,000. LFA Lugano Financial Advisors SA lifted its position in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 40 shares during the last quarter. Finally, Transcendent Capital Group LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $40,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently commented on UNH. JPMorgan Chase & Co. lifted their target price on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a report on Thursday, May 30th. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. TD Cowen dropped their price objective on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Truist Financial reissued a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Finally, Morgan Stanley dropped their price objective on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Three research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $579.74.

UnitedHealth Group Trading Up 0.7 %

NYSE UNH opened at $498.13 on Wednesday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. The company’s 50 day moving average price is $498.40 and its 200 day moving average price is $501.35. The firm has a market capitalization of $458.47 billion, a price-to-earnings ratio of 30.45, a PEG ratio of 1.48 and a beta of 0.60. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s revenue was up 8.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.26 earnings per share. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.55 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.69%. The ex-dividend date was Monday, June 17th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s payout ratio is currently 51.34%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.